Narrow search
Showing 1 - 10 of 47,341
Cover Image
The direct and indirect cost of diabetes in Italy : a prevalence probabilistic approach
Marcellusi, A.; Viti, R.; Mecozzi, A.; Mennini, F. S. - In: The European journal of health economics : HEPAC ; … 17 (2016) 2, pp. 139-147
Persistent link: https://www.econbiz.de/10011486436
Cover Image
Cost Estimates for Chronic Diseases
Woo, Jean; Cockram, Clive - In: Disease Management and Health Outcomes 8 (2000) 1, pp. 29-41
With increasing chronic disease and disability burden as a result of the aging of populations worldwide, cost estimates of disease and disability are important in determining: 1. the most cost-effective methods in delivering healthcare in order to maximise resources; and 2. health policies and...
Persistent link: https://www.econbiz.de/10005448788
Cover Image
Direct and Indirect Cost of Diabetes in Italy : A Prevalence Probabilistic Approach
Marcellusi, Andrea; Viti, Raffaella; Mecozzi, Alessandra; … - 2014
National Health Service (NHS) and society for the treatment of diabetes in Italy. Methods: A probabilistic prevalence Cost of … patients under drug therapies in Italy. The total economic burden of diabetic patients in Italy amounted to € 20.3 billion … conducted in Italy aimed at estimating direct and indirect cost of diabetes with a probabilistic prevalence approach. As it …
Persistent link: https://www.econbiz.de/10014143349
Cover Image
Why Don’t Blanchard-Kahn ever "Catch" Flu? And How it Matters for Measuring Indirect Cost of Epidemics in DSGE Framework
Torój, Andrzej - In: Central European Journal of Economic Modelling and … 5 (2013) 3, pp. 185-206
We attempt to apply a New Keynesian open economy model to simulate the economic consequences of influenza epidemic in Poland and measure the output loss (indirect cost) related to this disease. We introduce a negative health shock on the supply side of the economy and demonstrate that such a...
Persistent link: https://www.econbiz.de/10010875621
Cover Image
Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza
Aoki, Fred Y.; Fleming, Douglas M.; Griffin, Adrian D.; … - In: PharmacoEconomics 17 (2000) 2, pp. 187-195
Objective: This study examined the impact of zanamivir treatment on patient morbidity in patients with influenza. Design and setting: This was a multicentre, randomised, double-blind, parallel-group study conducted in 14 countries in Europe and North America during the winter of 1995/1996....
Persistent link: https://www.econbiz.de/10005243126
Cover Image
Long Term Cost-of-Illness in Stroke: An International Review
Payne, Krista A.; Huybrechts, Krista F.; Caro, Jjaime; … - In: PharmacoEconomics 20 (2002) 12, pp. 813-825
An international review of the costs of stroke was conducted to explore data sources, and cost variables as well as to compare estimates of the annual aggregated cost (prevalence-based) and total per patient long-term cost (incidence-based) of care. Dutch, English, French, German, Italian and...
Persistent link: https://www.econbiz.de/10005243167
Cover Image
Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making
Bloom, Bernard S.; Bruno, Douglas J.; Maman, Daniel Y.; … - In: PharmacoEconomics 19 (2001) 2, pp. 207-213
Objective: Cost-of-illness studies have been completed on scores of diseases over the past 30 years. The goal of this study was to review published cost-of-illness studies on US populations in order to evaluate the potential usefulness of the results in decision making. Methods: Medline and...
Persistent link: https://www.econbiz.de/10005448977
Cover Image
Workplace Productivity: A Review of the Impact of Migraine and its Treatment
Stang, Paul; Cady, Roger; Batenhorst, Alice; Hoffman, Lynn - In: PharmacoEconomics 19 (2001) 3, pp. 231-244
Migraine is a common disorder characterised by recurrent episodes of disability. Despite the high prevalence of migraine, data have been lacking on its impact in a working population. The advent of new therapies has stimulated interest in this area, and evidence is now available that documents...
Persistent link: https://www.econbiz.de/10005448980
Cover Image
The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, Charles E.; Annegers, John F.; Swann, Alan C.; … - In: PharmacoEconomics 19 (2001) 5, pp. 483-495
Objective: To develop a cost model that estimates the total and per case lifetime cost of bipolar disorder for 1998 incident cases in the US. Study design: Lifetime cost simulation model. Perspective: Societal. Methods: Age- and gender-specific incidence of bipolar disorder in 1998 was estimated...
Persistent link: https://www.econbiz.de/10005448988
Cover Image
The Impact of Pituitary Adenoma on Morbidity: Increased Sick Leave and Disability Retirement in a Cross-Sectional Analysis of Swedish National Data
Jonsson, Bjorn; Nilsson, Bo - In: PharmacoEconomics 18 (2000) 1, pp. 73-81
Objective: To quantify sick leave and medical retirement for the year 1989 in adults with a history of nonsecreting pituitary adenoma. Design and Setting: A cross-sectional analysis of official Swedish data from 1989 was performed. Sick leave and disability pension data for these patients were...
Persistent link: https://www.econbiz.de/10005449045